by In2Pharma | Jun 6, 2023 | News
Europe Following a question from a member state, the European Court has ruled that certain forms of price indications can incite irrational use, which is not allowed in public advertising of OTC medicines. They decided that the following situations incite irrational...
by In2Pharma | May 17, 2023 | News
Belgium Due to the publication of the Royal decree about fees for raw materials and products (RD of 13 novembre 2011), the amount of the fees for notifications of food supplements has been modified. From May 21st 2023, the fee for a food supplement notification will...
by In2Pharma | May 11, 2023 | News
Luxembourg As previously announced, IML, the association of the innovative pharmaceutical industry in Luxembourg has revised and updated their Code of Ethics. The proposed amendments have been approved at the General Assembly held on 17 April 2023. The amounts of...
by In2Pharma | May 10, 2023 | News
Belgium The Mixed Committee of the FAMHP (which examines the ‘grey zone’ products) has issued a new guideline regarding the use of D-mannose in food supplements. Products with an amount of D-mannose higher than 750 mg/day can have a significant...
by In2Pharma | Apr 3, 2023 | News
Europe Every year, the European Commission adopts a regulation adjusting the fees payable to the Agency with reference to the inflation rate in the European Union for the previous year. The 2022 inflation rate was 10.4%. The adjusted fees for all...